Home › Funds › SIGNET FINANCIAL MANAGEMENT, LLC › UTHR
SIGNET FINANCIAL MANAGEMENT, LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
SIGNET FINANCIAL MANAGEMENT, LLC reported holding 10,781 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q1 2026 13F filing — a position valued at US$6.4M, representing 0.72% of its reported portfolio and ranking #41 among its reported holdings. SIGNET FINANCIAL MANAGEMENT, LLC has disclosed UTHR holdings in 7 of the last 7 reported quarters, going back to Q3 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How SIGNET FINANCIAL MANAGEMENT, LLC's UTHR position evolved
SIGNET FINANCIAL MANAGEMENT, LLC first disclosed a stake in UTHR in Q3 2024 at 10,713 shares (US$3.8M). The position peaked in Q1 2026 at 10,781 shares, worth US$6.4M. Across 7 filings, SIGNET FINANCIAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 10,781 shares valued at US$6.4M — a reduction of -159 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 10.71K | $3.84M | New |
| Q4 2024 | 10.82K | $3.82M | Add |
| Q1 2025 | 10.89K | $3.36M | Add |
| Q2 2025 | 10.92K | $3.14M | Hold |
| Q3 2025 | 10.98K | $4.60M | Add |
| Q4 2025 | 10.94K | $5.33M | Hold |
| Q1 2026 | 10.78K | $6.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on SIGNET FINANCIAL MANAGEMENT, LLC
FAQ
How long has SIGNET FINANCIAL MANAGEMENT, LLC held UTHR?
SIGNET FINANCIAL MANAGEMENT, LLC has disclosed UTHR holdings in 7 of the last 7 reported quarters, going back to Q3 2024.
What is SIGNET FINANCIAL MANAGEMENT, LLC's current position in UTHR?
As of Q1 2026, SIGNET FINANCIAL MANAGEMENT, LLC holds 10.78K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $6.39M, representing 0.72% of its reported portfolio and ranking #41.
Has SIGNET FINANCIAL MANAGEMENT, LLC been buying or selling UTHR?
In the latest 13F filing (Q1 2026), SIGNET FINANCIAL MANAGEMENT, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 10.78K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.